Account
Inquiry
We are a factory specializing in the supply, wholesale, and customization of high - purity peptides, including Cagrilintide (CAS 1415456 - 99 - 3) with a purity of 99%. This product is for research use only and not provided for personal use. When discussing GLP - 1 agonists like Semaglutide and Tirzepatide, it's essential to understand semaglutide side effects, which is a key consideration for research on weight - loss and diabetes - related peptides.
GLP - 1 agonists, including Semaglutide, were approved by the FDA for weight loss in late 2014. These medications were initially designed to treat type II diabetes but some have also gained FDA approval for weight - loss treatment. When researching peptides like Cagrilintide, understanding semaglutide side effects can provide valuable insights into the safety and efficacy profiles of similar GLP - 1 - related compounds. Semaglutide is dosed at 0.5 - 2.4mg per week, and its side effects, along with its therapeutic effects, are important areas of study for researchers exploring weight - management and metabolic health.
Cagrilintide, as a high - purity (99%) peptide, has potential research applications in the field of metabolic disorders. Similar to other GLP - 1 - related peptides, studying semaglutide side effects can help researchers better assess the risk - benefit ratio of Cagrilintide in pre - clinical and clinical research settings. Our factory offers wholesale options, allowing research institutions and laboratories to procure this peptide in bulk, and we also provide customization services to meet specific research requirements, such as different formulations or purity levels.
The product function of GLP - 1 agonist - related peptides (relevant to the research context of Cagrilintide and semaglutide side effects research) includes helping slow food leaving the stomach, preventing the liver from producing too much sugar, aiding the pancreas in producing more insulin when blood sugar levels are high, controlling blood glucose, reducing hyperglycemia (especially after meals), reducing fasting insulin and fasting glucose, reducing hemoglobin A1c, decreasing appetite and caloric intake while inhibiting weight gain, lowering triglyceride levels and oxidative stress from high LDL, helping induce weight loss in obese patients with higher dosing, decreasing leptin and increasing leptin sensitivity, and increasing the conversion of white fat to brown fat. These functions, along with an understanding of semaglutide side effects, contribute to a comprehensive research framework for peptides like Cagrilintide.
For storage, Cagrilintide should be kept in a dry, dark environment. Short - term storage (days to weeks) can be at 0 - 4°C, and long - term storage (months to years) is recommended at - 20°C. Proper storage is crucial to maintain the peptide's stability, which is important for research experiments where consistent product quality is required. Our factory ensures that the product is shipped under ambient temperature as a non - hazardous chemical, and it remains stable for a few weeks during ordinary shipping and customs clearance, allowing for reliable delivery to research facilities.
